Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1989-1-3
|
pubmed:abstractText |
After intravenous administration of 1 g of cefpiramide, the biliary elimination of the drug was studied by using high-performance liquid chromatography. In five healthy volunteers, a mean peak concentration of 339 +/- 107 (standard error of the mean) micrograms/ml was measured in aspirated duodenal fluid during h 2 after administration, and 1.2% of the dose given was recovered over a 4-h period. A maximal concentration of 1,161 +/- 392 micrograms/ml was reached during h 2 in T-tube bile from 10 recently cholecystectomized patients, with a 24-h biliary recovery of 23.1%; urinary recovery over the same period averaged 49.4%. In 10 patients undergoing cholecystectomy, the concentrations in serum, choledochal bile, gallbladder bile, and gallbladder wall 1 h after cefpiramide administration were 157 +/- 21, 1,726 +/- 501, and 84 +/- 33 micrograms/ml and 23 +/- 4 micrograms/g, respectively. These figures represent the highest biliary concentrations attained so far with a beta-lactam antibiotic and are therefore a good prerequisite for treatment of biliary tract infections with cefpiramide.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-13389874,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-14373311,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-3301782,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-3558660,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-3877041,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-3925875,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-6426381,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-6549120,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-6619045,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3195998-6712202
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0066-4804
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1360-4
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:3195998-Anti-Bacterial Agents,
pubmed-meshheading:3195998-Bile,
pubmed-meshheading:3195998-Cephalosporins,
pubmed-meshheading:3195998-Cholecystectomy,
pubmed-meshheading:3195998-Chromatography, High Pressure Liquid,
pubmed-meshheading:3195998-Humans,
pubmed-meshheading:3195998-Liver
|
pubmed:year |
1988
|
pubmed:articleTitle |
High hepatic excretion in humans of cefpiramide, a new cephalosporin.
|
pubmed:affiliation |
Department of Internal Medicine, Hospital-University Center of Strasbourg, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|